Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Logitech International SA (LOGI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Logitech International SA — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.53 (market cap $5.85B), while Logitech International SA trades at $101.34 (market cap $14.63B). The key difference: Logitech International SA is far larger — about 2.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and Logitech International SA pays a 1.62% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Logitech International SA for 92 Days on average.
| IOVA | LOGI | |
|---|---|---|
Market Cap | $5.85B | $14.63B |
Volume | 14,517,176 | 440,764 |
Sector | Health | Technology |
52-Week High | $14.82 | $126.69 |
52-Week Low | $1.81 | $85.84 |
Typical Hold Time | 0 Days | 92 Days |
Enterprise Value | $5.78B | $12.96B |
Dividend Yield | — | 1.62% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Logitech (LOGI) trades at $101.50, down 0.89% today, with a bullish technical signal and strong fundamental performance. Recent earnings beats, including Q2 2026 EPS of $1.85 versus $1.26 expected, highlight operational strength. The company maintains robust profitability with a net margin of 16.28% and ROE of 35.29%, supported by new product launches like the Zone Vibe Pro headset and gaming partnerships.
Outlook remains positive with analyst consensus target of $107, offering ~5% upside, though risks include chip shortages and competitive pressures. Revenue growth is projected to reach $4.9B in 2026, but investor sentiment is mixed amid macroeconomic headwinds. The stock's valuation at P/E 18.75 appears reasonable given earnings trajectory.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →
